These findings suggest that CD133 and Oct3/4 in cholangiocarcinoma are highly associated with formation of DNA lesions, which may be involved in genetic instability and lead to tumor development with aggressive clinical features. This evidence concerns the gene PROM1 and cholangiocarcinoma.